Does genetic variation in genes controlling pro-inflammatory immune responses modulate outcomes of MIS416 treatment in patients with multiple sclerosis? (2017–2019)

Grant type:
Wesley Medical Research Ltd
Researchers:
Funded by:
Wesley Medical Research Ltd